Ercros (ECR) - Total Assets
Based on the latest financial reports, Ercros (ECR) holds total assets worth €768.68 Million EUR (≈ $898.67 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ercros - Total Assets Trend (2000–2025)
This chart illustrates how Ercros's total assets have evolved over time, based on quarterly financial data. Also see ECR market cap overview for the company's overall valuation and market capitalisation.
Ercros - Asset Composition Analysis
Current Asset Composition (December 2025)
Ercros's total assets of €768.68 Million consist of 35.4% current assets and 64.6% non-current assets. Review total liabilities of Ercros to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.8% |
| Accounts Receivable | €46.48 Million | 6.7% |
| Inventory | €102.15 Million | 14.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €21.28 Million | 3.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Ercros's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ECR stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ercros's current assets represent 35.4% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2025, up from 1.7% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 14.7% of total assets.
Ercros Competitors by Total Assets
Key competitors of Ercros based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Methanex Corporation
TO:MX
|
Canada | CA$7.17 Billion |
|
Sichuan Em Technology Co Ltd
SHG:601208
|
China | CN¥11.08 Billion |
|
Tangshan Sunfar Silicon Ind
SHG:603938
|
China | CN¥3.42 Billion |
|
Solvac S.A.
BR:SOLV
|
Belgium | €2.73 Billion |
|
Robertet SA
PA:RBT
|
France | €1.00 Billion |
|
Anhui Hwasu Co.Ltd.
SHG:600935
|
China | CN¥9.31 Billion |
|
Shanghai Zhongyida Co Ltd A
SHG:600610
|
China | CN¥1.04 Billion |
|
Shandong Jincheng Pharmaceutical and Chemical Co Ltd
SHE:300233
|
China | CN¥5.21 Billion |
Ercros - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 1.50 | 1.25 |
| Quick Ratio | 0.61 | 1.01 | 0.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-4.51 Million | €98.08 Million | €48.02 Million |
Ercros - Advanced Valuation Insights
This section examines the relationship between Ercros's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.46 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | €694.30 Million |
| Market Capitalization | $319.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ercros's assets below their book value (0.46x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Ercros's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Ercros (2000–2025)
The table below shows the annual total assets of Ercros from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €694.30 Million ≈ $811.71 Million |
-0.70% |
| 2024-12-31 | €699.19 Million ≈ $817.43 Million |
+2.32% |
| 2023-12-31 | €683.32 Million ≈ $798.87 Million |
-8.47% |
| 2022-12-31 | €746.55 Million ≈ $872.80 Million |
+5.15% |
| 2021-12-31 | €709.96 Million ≈ $830.01 Million |
+20.29% |
| 2020-12-31 | €590.22 Million ≈ $690.03 Million |
-10.08% |
| 2019-12-31 | €656.41 Million ≈ $767.42 Million |
+8.22% |
| 2018-12-31 | €606.57 Million ≈ $709.15 Million |
+1.23% |
| 2017-12-31 | €599.17 Million ≈ $700.50 Million |
+6.96% |
| 2016-12-31 | €560.18 Million ≈ $654.91 Million |
+9.48% |
| 2015-12-31 | €511.68 Million ≈ $598.21 Million |
-1.74% |
| 2014-12-31 | €520.72 Million ≈ $608.78 Million |
-7.72% |
| 2013-12-31 | €564.29 Million ≈ $659.71 Million |
-6.76% |
| 2012-12-31 | €605.18 Million ≈ $707.52 Million |
-0.06% |
| 2011-12-31 | €605.56 Million ≈ $707.96 Million |
-3.37% |
| 2010-12-31 | €626.69 Million ≈ $732.67 Million |
-2.09% |
| 2009-12-31 | €640.10 Million ≈ $748.34 Million |
-9.47% |
| 2008-12-31 | €707.03 Million ≈ $826.59 Million |
-25.50% |
| 2007-12-31 | €949.03 Million ≈ $1.11 Billion |
-5.64% |
| 2006-12-31 | €1.01 Billion ≈ $1.18 Billion |
+32.03% |
| 2005-12-31 | €761.81 Million ≈ $890.64 Million |
+110.52% |
| 2004-12-31 | €361.87 Million ≈ $423.06 Million |
+2.35% |
| 2003-12-31 | €353.55 Million ≈ $413.34 Million |
+3.94% |
| 2002-12-31 | €340.14 Million ≈ $397.66 Million |
+0.68% |
| 2001-12-31 | €337.84 Million ≈ $394.97 Million |
-99.41% |
| 2000-12-31 | €56.93 Billion ≈ $66.56 Billion |
-- |
About Ercros
Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl ch… Read more